Address And Details

PO Box 55932 , Boston, MA 02205-5932
Fund Manager Matthew Peron
Manager Tenure 1 Years 5 Months

Strategy And Objective

Janus Henderson Research Fund seeks long-term growth of capital. The Fund pursues its investment objective by investing primarily in common stocks selected for their growth potential. The Fund may invest in companies of any size, from larger, well-established companies to smaller, emerging growth companies. Janus Capital s equity research analysts, overseen by the Portfolio Oversight Team led by Janus Capital s Director of Centralized Equity Research Matthew Peron (the Central Research Team ), select investments for the Fund that represent the Central Research Team s high-conviction investment ideas in all market capitalizations and styles. The Central Research Team, comprised of sector specialists, conducts fundamental analysis with a focus on bottom up research, quantitative modeling, and valuation analysis. Using this research process, analysts rate their stocks based upon attractiveness. Stocks considered to be attractive may have all or some of the following characteristics: (i) good and preferably growing free cash flow, (ii) strong and defensible market position, (iii) healthy risk/return profile, (iv) exemplary governance, and (v) attractive valuation. Analysts bring their high-conviction ideas to their respective sector teams. Sector teams compare the appreciation and risk potential of each of the team s high-conviction ideas and construct a sector portfolio that is intended to maximize the best risk-reward opportunities. Although the Central Research Team may find high-conviction investment ideas anywhere in the world, the Central Research Team emphasizes investments in securities of U.S.-based issuers. Positions may be sold when, among other things, there is no longer high conviction in the return potential of the investment, if the risk characteristics have caused a re-evaluation of the opportunity, or if the investment thesis for owning a position has changed. This may occur if the stock has appreciated and reflects the anticipated value, if another company represents a better risk-reward opportunity, or if the investment s fundamental characteristics deteriorate. Securities may also be sold from the portfolio to rebalance sector weightings. Mr. Peron oversees the investment process and is responsible for the day-to-day management of the Fund. It is expected that the Fund will be broadly diversified among a variety of industry sectors. The Fund intends to be fully invested under normal circumstances. However, under unusual circumstances, if the Central Research Team does not have high conviction in enough investment opportunities, the Fund s uninvested assets may be held in cash or similar instruments. The Fund may lend portfolio securities on a short-term or long-term basis, in an amount equal to up to one-third of its total assets as determined at the time of the loan origination.

Net Asset Value

as of 5:34 PM ET 09/24/2021

Performance

  • 1 Week
  • +0.48%
  • 1 Month
  • +0.42%
  • 3 Months
  • +4.51%
  • 1 Yr Return
  • +29.78%
  • 5 Yr Return
  • +74.12%

Equity Sector Breakdown

Technology 50.32%
RetailTrade 15.74%
NonDurables 7.67%
Finance 6.87%
IndustrialCyclical 5.57%
Health 4.70%
Services 2.03%
ConsumerDurables 1.89%
Utilities 0.37%
Energy n/a

Asset Allocation

Asset Type % Of Allocation
Stocks 99.12%
ForeignStocks 2.47%
Preferred 0.02%
Cash 0.00%
Bonds 0.00%
Convertible 0.00%
Other 0.00%
ForeignBonds 0.00%
ForeignHedged 0.00%
Total Net Assets 56.23 M

Risk Measures

Criteria 3 Years 5 Years 10 Years
Alpha 2.18 1.88 0.21
Beta 1.03 1.02 1.04
R Squared 0.94 0.91 0.91
Std Deviation 19.69 16.00 14.62
Sharpe Ratio 1.11 1.29 n/a

Purchase Information

as of 5:45 PM ET 09/23/2021
Minimum Initial $2500
Minimum Additional $0
Minimum Initial IRA $500

Performance

Timeframe Average Annual Current Performance Monthly As Of 08/31/2021 Average Annual Current Performance Quarterly As Of 06/30/2021 Avg Annual Current Performance Monthly As Of 08/31/2021 Avg Annual Current Performance Quarterly As Of 06/30/2021
1 Year
  • +23.06%
  • +37.79%
+23.06% +37.79%
3 Year
  • +20.95%
  • +22.47%
+20.95% +22.47%
10 Year
  • +17.11%
  • +15.58%
+17.11% +15.58%
Life Of Fund
  • +17.62%
  • +17.43%
+17.62% +17.43%

Top 10 Holdings

Symbol Company Name % Of Assets
MSFT MICROSOFT CORP 8.93%
AMZN AMAZON COM INC 7.57%
GOOGL ALPHABET INC CLASS A 6.29%
AAPL APPLE INC 4.56%
NVDA NVIDIA CORP 4.46%
FB FACEBOOK INC 4.20%
ADBE ADOBE INC 3.52%
MA MASTERCARD INC 3.23%
V VISA INC 3.13%
LRCX LAM RESEARCH CORP 1.72%

LATEST NEWS

Recent Articles from TheStreet

Nikola

Tim Collins on How to Trade Nikola

Technical setups and short interest make much hated name volatile, and therefore interesting.

Chinese Firms Should Face Faster US Stock Delisting Over Audit Rules, SEC Chairman Gary Gensler Tells Lawmakers

Jim Cramer: Gensler's Plate is Very Full

SEC Chairman is key player in efforts to rein in ceaseless financial engineering.

stocks rise asset management sh

Cramer's Mad Money Recap: Advanced Micro Devices, Nvidia, Thor

Jim Cramer has your game plan for next week, which he says will be the calm before the earnings season storm.

Jim Cramer: Starbucks Needs More Traffic in Stores

Starbucks Resists Union Effort in New York Region: Report

Starbucks reportedly said it will raise wages and benefits and a union isn’t needed, to employees at three stores in Buffalo New York.

Exxon Mobil

Exxon, Occidental, Baker Hughes Make Goldman Turnaround List

Exxon has 'reduced costs, surprised to the downside on capital spending, outperformed our expectations in downstream/chemicals,' Goldman said.

videoblocks-a-series-of-fullhd-close-up-rotating-slider-dollymacro-shots-of-the-surface-of-computer-hardware-parts-chipsmotherboardcpucurcuits-close-up-macro-computer-chips-circuits-surface-rotating-dolly_s_mt0i43g_1080__D

Jim Cramer is Tired of the Weak Response to Chip Shortages

Companies need to forget about help from Washington and step up to the plate.

Microsoft Lead

Why 'Sarge' Guilfoyle Isn't Selling His Microsoft

Sharp management and strength across its business lines are keys to software giant.

Why Charles River Labs Is the Biotech Stock to Buy: Jim Cramer

Bret Jensen: Paratek Deal Shows Promise

While antibiotics are usually less profitable and slower to develop market share than other drugs, Paratek has a key factor in its favor.

Stocks Close Higher as Wall Street Dissects New Tax Laws

Stocks End Mixed Amid Evergrande Default Saga, Supply Chain Chaos

Evergrande's default saga, as well as mounting supply chain issues, have stocks trading mixed Friday.

bitcoin copy

Stock Market Today With Jim Cramer: China's Crypto Clampdown

Jim Cramer discusses China's crypto clampdown and Nike's report.